Annotation Detail for FAM83A

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C015001 |
arsenite |
arsenite results in decreased expression of FAM83A mRNA | decreases expression | 19716837
|
C015001 |
arsenite |
arsenite results in increased methylation of FAM83A promoter | increases methylation | 19716837
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of FAM83A promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
C014347 |
decitabine |
decitabine inhibits the reaction [sodium arsenite affects the methylation of FAM83A promoter] | affects methylation|decreases reaction | 18448484
|
C406082 |
monomethylarsonous acid |
[monomethylarsonous acid affects the acetylation of HIST3H3 protein] which affects the methylation of FAM83A promoter | affects acetylation|affects methylation | 18448484
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in decreased expression of FAM83A mRNA | decreases expression | 19716837 18448484
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in increased methylation of FAM83A promoter | increases methylation | 19716837
|
C017947 |
sodium arsenite |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of FAM83A promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
C017947 |
sodium arsenite |
decitabine inhibits the reaction [sodium arsenite affects the methylation of FAM83A promoter] | affects methylation|decreases reaction | 18448484
|
C017947 |
sodium arsenite |
[sodium arsenite affects the acetylation of HIST3H3 protein] which affects the methylation of FAM83A promoter | affects acetylation|affects methylation | 18448484
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of FAM83A mRNA | decreases expression | 18448484
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of FAM83A promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.31 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.51 | 16712894 17306315 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.54 | 19208741 18320071 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
2.00 | 16507464 17306315 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
5.08 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
5.08 | 18572023 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
7.96 | 19716837 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.96 | 20056578 19524636 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
4.17 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
4.17 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
16.16 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
16.16 | 19294695 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
4.15 | 18296743 |
MESH:D005355 |
Fibrosis |
|
arsenite |
4.55 | 18296743 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.22 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
4.05 | 18801729 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.71 | 19215824 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.47 | 12676792 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
7.66 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.66 | 15346721 12646999 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.98 | 20008137 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.22 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.37 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.44 | 18206229 19010910 18704418 18460780 19387464 17679729 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.44 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
6.07 | 18055864 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.59 | 18296743 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.47 | 16712894 15276417 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.40 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
2.80 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.80 | 16712894 17077188 17306315 19931552 15276417 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.66 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
5.55 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.55 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
5.55 | 16505122 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
8.49 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
8.49 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.56 | 18608210 19157545 16882708 19010910 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.73 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.73 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.15 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.95 | 15738583 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.36 | 12854658 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
8.57 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
8.57 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
8.57 | 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
6.03 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
6.03 | 19294695 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
14.09 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
14.09 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.50 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
3.50 | 19789329 18798265 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.81 | 19155313 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.45 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.84 | 18572023 19524636 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.07 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.60 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
9.20 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
9.20 | 20375083 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
9.20 | 17306315 16452187 16712894 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.11 | 11813266 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.52 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.96 | 17056641 |